StockpollyBeta
Get App
Popularity #2,616
ALMR · NASDAQ · Biotechnology

Alamar Biosciences (ALMR)

Supplies NULISA assays and ARGO HT automation for protein-biomarker measurement.

$32.37
vs last close−0.85 (−2.56%)

Something off on this page? Send us feedback.

13F · 13D/G · Form 4

Institutions35.29%24.49M shares
87 holders · as of Jun 30, 2026
Insiders29.47%20.45M shares
8 holders · as of Sep 16, 2026
Strategic holders22.68%15.74M shares
1 holder · as of Aug 11, 2026
Other12.56%8.71M shares
remainder

69.39M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing

13F · 13D/G · Form 4

HolderStakeSharesDate
Qiming Corporate GP VI, Ltd.1Strategic10 percent owner
22.68%7.07M · 8.67Mfiled Aug 11, 2026
Yuling Luo2Insiderdirector, officer: Chief Executive Officer
9.21%4.53M · 1.86Mfiled Aug 13, 2026
Nicholas NaclerioInsiderdirector
9.18%6.37Mfiled Apr 20, 2026
Nicholas NaclerioInsider
9.17%6.36Mfiled Apr 23, 2026
Sands Capital Ventures, LLCInstitution
6.10%4.23Mas of Jun 30, 2026
Sherpa Healthcare Fund Ii, L.P.Institution
5.72%3.97Mfiled Jul 2, 2026
Samsara Biocapital, LLCInstitution
3.57%2.48Mas of Jun 30, 2026
T. Rowe Price Investment Management, Inc.Institution
3.17%2.20Mas of Jun 30, 2026
Ark Investment Management LLCInstitution
1.98%1.37Mas of Jun 30, 2026
Braidwell LPInstitution
1.56%1.08Mas of Jun 30, 2026
AllianceBernstein L.P.Institution
1.45%1.00Mas of Jun 30, 2026
HHLR Advisors, Ltd.Institution
1.38%956,462as of Jun 30, 2026
BlackRock, Inc.Institution
1.31%911,445as of Jun 30, 2026
Millennium Management LLCInstitution
1.25%865,764as of Jun 30, 2026
FMR LLCInstitution
1.20%829,424as of Jun 30, 2026
Shiping ChenInsiderdirector, officer: Chief Operating Officer
1.10%760,105filed Apr 20, 2026
Pura Vida Investments, LLCInstitution
1.09%755,909as of Jun 30, 2026
Emerald Advisers, LLCInstitution
0.93%647,183as of Jun 30, 2026
Artisan Partners Limited PartnershipInstitution
0.88%613,744as of Jun 30, 2026
Deerfield Management Company, L.P. (Series C)Institution
0.86%600,000as of Jun 30, 2026
Timothy Ogden WhiteInsiderofficer: President
0.71%491,803filed Apr 20, 2026
Vanguard Capital Management LLCInstitution
0.67%463,385as of Jun 30, 2026
Farallon Capital Management LLCInstitution
0.67%462,900as of Jun 30, 2026
Wellington Management Group LLPInstitution
0.66%457,974as of Jun 30, 2026
Emerald Mutual Fund Advisers TrustInstitution
0.61%422,127as of Jun 30, 2026
  1. Qiming Corporate GP VI, Ltd.'s own ownership statement (13G, Aug 11, 2026) reports fewer shares than the transaction reports; the statement is used.
  2. Yuling Luo's transaction reports restate only vehicles that traded; the 2026 ownership statement (4.53M) is used instead.

13F, as of Jun 30, 2026

87 holders · 24.49M shares · 87 new positions · 87 increased · 0 reduced · 0 closed

HolderShares% outstandingChg q/qFiled
Sands Capital Ventures, LLC4.23M6.10%+4.23MnewAug 13, 2026
Samsara Biocapital, LLC2.48M3.57%+2.48MnewAug 14, 2026
T. Rowe Price Investment Management, Inc.2.20M3.17%+2.20MnewAug 14, 2026
Ark Investment Management LLC1.37M1.98%+1.37MnewAug 14, 2026
Braidwell LP1.08M1.56%+1.08MnewAug 14, 2026
AllianceBernstein L.P.1.00M1.45%+1.00MnewAug 14, 2026
HHLR Advisors, Ltd.956.5K1.38%+956.5KnewAug 14, 2026
BlackRock, Inc.911.4K1.31%+911.4KnewAug 7, 2026

13D/G · 5% or more, as filed

Holder% of classSharesFormFiled
Qiming Corporate GP VI, Ltd10.20%7.07M13GAug 11, 2026
Nicholas Naclerioincl. Illumina Innovation Fund II GP, L.L.C., Illumina Innovation Fund II, L.P. +2 more9.60%6.36M13DApr 23, 2026
Yuling Luo6.40%4.53M13GAug 13, 2026
Sands Capital Alternatives, LLCincl. Sands Frank M., Sands Capital Life Sciences Pulse Fund II, L.P.6.10%4.23M13DJul 7, 2026
Sherpa Healthcare Fund Ii, L.P.5.70%3.97M13GJul 2, 2026

Form 4

Latest trades

DateInsiderTypeSharesAvg priceOwned after
Apr 20, 2026
Nicholas Nacleriodirector
Purchase235,294$17.00507,076
Apr 20, 2026
Illumina Innovation Fund II GP, L.L.C.10 percent owner
Purchase235,294$17.00507,076

House and Senate disclosures

Not reported.